Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EXENATIDE Cause Transient ischaemic attack? 39 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Transient ischaemic attack have been filed in association with EXENATIDE (Exenatide). This represents 0.1% of all adverse event reports for EXENATIDE.

39
Reports of Transient ischaemic attack with EXENATIDE
0.1%
of all EXENATIDE reports
4
Deaths
21
Hospitalizations

How Dangerous Is Transient ischaemic attack From EXENATIDE?

Of the 39 reports, 4 (10.3%) resulted in death, 21 (53.8%) required hospitalization, and 5 (12.8%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EXENATIDE. However, 39 reports have been filed with the FAERS database.

What Other Side Effects Does EXENATIDE Cause?

Injection site haemorrhage (5,527) Device leakage (5,115) Injection site pain (4,577) Injection site mass (3,506) Blood glucose increased (3,363) Incorrect dose administered by device (3,332) Device malfunction (3,273) Wrong technique in device usage process (3,255) Device issue (2,862) Weight decreased (2,702)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which EXENATIDE Alternatives Have Lower Transient ischaemic attack Risk?

EXENATIDE vs EXFORGE EXENATIDE vs EXJADE EXENATIDE vs EXTAVIA EXENATIDE vs EXTRANEAL EXENATIDE vs EYLEA

Related Pages

EXENATIDE Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack EXENATIDE Demographics